Celltrion's COVID-19 Treatment Prescribed to More Patients

  • Arirang News

    November 25, 2021 08:25

    Health authorities are expanding the use of the COVID-19 antibody treatment Regkirona, which was developed by Korean bio-pharmaceutical company Celltrion.

    From Thursday, Regkirona is being supplied to nursing and quarantine facilities to prevent COVID-19 patients with mild symptoms from developing more serious illness.

    Previously, the antibody treatment was only given to patients hospitalized with severe COVID-19. It has been administered to more than 23,000 patients nationwide so far.

    • Copyright © Chosunilbo & Chosun.com
    Previous Next
    All Headlines Back to Top